Remove Marketing Remove Medical science Remove Physicians
article thumbnail

What Physicians Want from Pharma—And Where—During Diagnosis and Treatment

PM360

For life sciences commercial teams, effectively engaging physicians and supporting them with education on the evolving science around products and conditions requires a deep understanding of physician content needs and channel preferences. physicians across 15 specialties, treating more than 95 conditions.

article thumbnail

2022 Pharma Marketing Trend to Watch: Musical Chairs

Eversana Intouch

As what Harvard Business Review calls “a tidal wave of resignations” continues — with the highest rates for those ages 30-45 — and, as many pandemic-induced changes continue to alter to the structure of businesses worldwide (including pharma sales and marketing organizations) — many of our basic assumptions, approaches, and priorities need to shift.

article thumbnail

Biologic Prices Decreasing As More Commercial Health Plans Allow Biosimilars as First-Line Options

PM360

When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. So, that’s quite the hurdle for access, I think.

article thumbnail

5 Quick Tips for MSL When Engaging KOLs

Clarity Engagement Solutions

The primary purpose of Medical Science Liaison MSL is to establish and maintain peer-peer relationships with leading physicians, referred to as Key Opinion Leaders KOL’s, at major academic institutions and clinics. We have highlighted 5 quick tips for MSL to aid them through the process when engaging with KOL’s.

article thumbnail

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Medgadget

This new way of controlling laparoscopic tools the company describes as “endo-robotic surgery” Its leadership sees it as being able to disrupt the existing market, thanks to significant cost reductions, all while offering surgeons capabilities previously only available from very expensive robotic systems.

article thumbnail

Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile

Clarify Health

Each drug on the market started off as an idea that successfully overcame many hurdles while thousands (and sometimes millions) of other potential therapies failed along the way. After FDA-approval comes the last critical mile of this journey: bringing the product to market. sales, medical science liaisons, etc.).

article thumbnail

3 Things Generative AI Can Do for Commercial Pharma Right Now

PM360

Accelerated Content Creation and Organization Personalized engagement is crucial for successful commercialization, especially as more physicians have come to expect it from their online interactions as consumers. From manufacturing to marketing, few business sectors have not already been impacted by the emergence of generative AI/LLMs.

Pharma 97